Ocumetics Achieves Historic First: Accommodating Intraocular Lens Successfully Implanted in Human Patients

Ocumetics Technology Corp.'s (CVE:OTC) 261% gain last week benefited both individual investors who own 56% as well as insiders

Ocumetics Completes One-Month Postoperative Examinations - Results Pending

Ocumetics Reports Second Successful Surgery Day

Ocumetics Reports Encouraging One-Month Postoperative Results

Ocumetics Reports Continued Improvement in First Group of Patients. Early Vision Results Surpass Expectations

Ocumetics Reports Positive Three Month First-in-Human Results, Significantly De-Risking Its Accommodating Intraocular Lens Technology

Ocumetics Technology Corp. Achieves Breakthrough in Next-Generation Accommodating Intraocular Lens Design

Ocumetics Reports Improvement in Six Month First-in-Human Results Meaningful Improvements in Patient Quality of Life

Ocumetics Accelerates Toward Group Two First-In-Human Study With Manufacturing Launch of Optimized Accommodating Lens